Skip to content

English
Français

Careers
Contact Us

About DBV
- Overview
- Leadership
Our Pipeline
- Overview
- Clinical Trials
- VIASKIN^® peanut patch
- VIASKIN^® milk patch
- VIASKIN^® milk patch for EoE
- Expanded Access Program
Our Science
Investors
Newsroom
- Press Releases
- Media Kit

News

News

Select Year
Search News

Found 505 Results

Page 17 of 51« First «...10...15 161718 19...30 40 50...»Last »

November 24, 2021

DBV Technologies to Participate in an Upcoming Investor Conference

November 1, 2021

DBV Technologies to Highlight New Long-term Data from REALISE Trial at ACAAI 2021

October 26, 2021

DBV Technologies Reports Third Quarter 2021 Financial Results and Recent Regulatory Developments

August 31, 2021

DBV Technologies to Participate at Upcoming Investor Conferences

August 6, 2021

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

August 2, 2021

DBV Technologies Reports Second Quarter 2021 Financial Results and Recent Business Developments

July 26, 2021

DBV Technologies to Report First Half 2021 Financial Results and Business Updates on August 2, 2021

June 2, 2021

DBV Technologies to Present at Upcoming Investor Conferences

May 19, 2021

DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting and the Appointment of Dr. Adora Ndu, Pharm.D., J.D., and Dr. Ravi Madduri Rao, M.D., Ph.D., as Members of its Board of Directors

May 5, 2021

DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021

Page 17 of 51« First «...10...15 161718 19...30 40 50...»Last »

Investor Relations Contact

Jonathan Neely

+1 848-388-4584

jonathan.neely@dbv-technologies.com

Media Contact

Brett Whelan

+1 848-350-7622

brett.whelan@dbv-technologies.com

Subscribe to get the latest DBV press releases

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

Homepage
About DBV
Our Pipeline
Our Science
News
Investors
Careers
Contact Us

© 2026 DBV Technologies. All rights reserved.
Les traitements de DBV Technologies sont expérimentaux et ne sont pas approuvés par la FDA.

Terms of Use
Privacy Policy
Legal Notice
Cookies Policy

Scroll to Top